Informação sobre produto
LAS101057 is a drug candidate that inhibits the enzyme HMG-CoA reductase, which is responsible for the production of cholesterol in the liver. LAS101057 has been shown to have potential therapeutic effects on symptoms associated with insulin resistance and hyperresponsiveness in animal models. This drug has also been shown to reduce inflammation and increase adenosine levels in human fibroblasts. LAS101057 is currently being studied as a treatment for Alzheimer's disease and anxiety disorders. This drug also blocks the A2A receptor and reduces neuronal death after brain injury, suggesting it may be used to treat strokes.
Propriedades químicas
Consulta técnica sobre: 3D-AMB67648 LAS101057
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
